suministro del principio activo denominado DOLUTEGRAVIR 50 mg/LAMIVUDINA 300 mg COMPRIMIDOS ORAL (DOVATO) para el Servicio de Farmacia del Complejo Hospitalario Universitario de Canarias
Awarded
The competition has ended and a winner has been selected.
- Qualification deadline
- Mar 3, 2024Expired
- Award
- Price only
Brief
suministro del principio activo denominado DOLUTEGRAVIR 50 mg/LAMIVUDINA 300 mg COMPRIMIDOS ORAL (DOVATO) para el Servicio de Farmacia del Complejo Hospitalario Universitario de Canarias
Farmasøytisk engroshandel
Result
- ViiV HEALTHCARE, S.L.Winner
- 1Number of bids
- €606,405Contract value
Custom Assessment Criteria
Get answers to your bid/no-bid criteria
Set them up once and Cobrief answers them in every tender
Will you bid?
The agent sets up the bid and writes the first draft. Free for 14 days.
Award Criteria
Description
OFERTA ECONÓMICA.
Source
No source found in the documents. Check the weight against the tender documents.
Previous winners
Who are you up against?
The suppliers who have won similar contracts at Dirección Gerencia del Complejo Hospitalario Universitario de Canarias
From the notice
suministro del principio activo denominado DOLUTEGRAVIR 50 mg/LAMIVUDINA 300 mg COMPRIMIDOS ORAL (DOVATO) para el Servicio de Farmacia del Complejo Hospitalario Universitario de Canarias
Contact
Dirección Gerencia del Complejo Hospitalario Universitario de Canariascontadmhuc.scs@gobiernodecanarias.org- Result · PrequalificationType
- El Hierro, Fuerteventura, Gran Canaria, La Gomera, La Palma, Lanzarote, TenerifeLocation
- 33690000Main codeVarious medicinal products